Realm Therapeutics Announces Publication of Pre-Clinical Study Demonstrating Comparable Activity of PR022 and Topical Tofacitinib in the Treatment of Atopic Dermatitis
Mississippi News Now ,
SOURCE Realm Therapeutics MALVERN, Pa. Researchers compared the effect of topical administration of PR022 and tofacitinib on…